Omega Healthcare Investors (BSP:O2HI34) Debt-to-Equity: 0.86 (As of Mar. 2026) — 34% Below Median


BSP:O2HI34 Omega Healthcare Investors Inc BSP:O2HI34
49 GF Score
Price R$77.02
GF Value R$60.64
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Omega Healthcare Investors Debt-to-Equity?

Omega Healthcare Investors BSP:O2HI34 -0.03% 49 Debt-to-Equity is 0.86 as of Mar. 2026, which is 34% below its 10-year median of 1.30. GuruFocus rates BSP:O2HI34 with a GF Score™ of 49/100 and a GF Value™ of R$60.64 (Modestly Overvalued). The stock has 6 warning signs investors should review. Among 696 REITs companies, Omega Healthcare Investors ranks worse than 57.47% on this metric.

Omega Healthcare Investors's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2026 was R$2,223 Mil. Omega Healthcare Investors's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2026 was R$21,004 Mil. Omega Healthcare Investors's Total Stockholders Equity for the quarter that ended in Mar. 2026 was R$27,149 Mil. Omega Healthcare Investors's debt to equity for the quarter that ended in Mar. 2026 was 0.86.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Omega Healthcare Investors's Debt-to-Equity or its related term are showing as below:

BSP:O2HI34' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.82   Med: 1.3   Max: 1.51
Current: 0.86

During the past 13 years, the highest Debt-to-Equity Ratio of Omega Healthcare Investors was 1.51. The lowest was 0.82. And the median was 1.30.

BSP:O2HI34's Debt-to-Equity is ranked worse than
57.47% of 696 companies
in the REITs industry
Industry Median: 0.79 vs BSP:O2HI34: 0.86

Omega Healthcare Investors  (BSP:O2HI34) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Omega Healthcare Investors Debt-to-Equity Related Terms


Omega Healthcare Investors Debt-to-Equity Historical Data

* Premium members only.

The historical data trend for Omega Healthcare Investors's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Omega Healthcare Investors Debt-to-Equity Chart

Omega Healthcare Investors Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.35 1.47 1.42 1.07 0.82

Omega Healthcare Investors Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.94 1.00 0.99 0.82 0.86

BSP:O2HI34 vs DOC, AHR, CTRE: Debt-to-Equity Comparison

For the REIT - Healthcare Facilities subindustry, Omega Healthcare Investors's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Omega Healthcare Investors Debt-to-Equity vs REITs Industry

For the REITs industry and Real Estate sector, Omega Healthcare Investors's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Omega Healthcare Investors's Debt-to-Equity falls into.


BSP:O2HI34
49GF Score
Omega Healthcare Investors Inc BSP:O2HI34
Debt-to-Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Omega Healthcare Investors Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Omega Healthcare Investors's Debt to Equity Ratio for the fiscal year that ended in Dec. 2025 is calculated as

Omega Healthcare Investors's Debt to Equity Ratio for the quarter that ended in Mar. 2026 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Debt-to-Equity →
What does a Debt-to-Equity of 0.86 mean?
Omega Healthcare Investors (BSP:O2HI34) has a Debt-to-Equity of 0.86 as of Mar. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Omega Healthcare Investors and its competitors. This is 34% below median its historical median of 1.30. Over the past decade, Omega Healthcare Investors' Debt-to-Equity has ranged from 0.82 to 1.51. According to the industry distribution chart, Omega Healthcare Investors ranks #400 out of 696 companies in the REITs industry, placing it in the top 57.5%.
Is Omega Healthcare Investors' Debt-to-Equity too high?
Omega Healthcare Investors' current Debt-to-Equity of 0.86 is 34% below median its 10-year median of 1.30. Over the past 10 years, this metric has ranged from a low of 0.82 to a high of 1.51. The REITs industry median Debt-to-Equity is 0.79. Omega Healthcare Investors' value of 0.86 is 8.9% above this industry median. Based on the distribution chart, Omega Healthcare Investors ranks #400 out of 696 companies in the REITs industry, which is below the industry midpoint. Overall, Omega Healthcare Investors has a GF Score™ of 49/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Omega Healthcare Investors' Debt-to-Equity compare to DOC and AHR?
According to the REITs industry distribution chart, Omega Healthcare Investors ranks #400 out of 696 companies for Debt-to-Equity. This places Omega Healthcare Investors in the lower half of its industry. The industry median Debt-to-Equity is 0.79. Omega Healthcare Investors' value of 0.86 is 8.9% above this benchmark. Historically, Omega Healthcare Investors' own Debt-to-Equity has ranged from 0.82 to 1.51 over the past decade. While the company's 10-year median is 1.30 vs. the industry median of 0.79, Omega Healthcare Investors has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a REITs company?
The median Debt-to-Equity among REITs companies is 0.79, based on 696 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Omega Healthcare Investors's current Debt-to-Equity of 0.86 is 8.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Omega Healthcare Investors and its competitors. For the REITs industry, the median Debt-to-Equity is 0.79 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Omega Healthcare Investors's current Debt-to-Equity is 0.86, which is 34% below median its own 10-year median of 1.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Omega Healthcare Investors stock overvalued right now?
Based on GuruFocus' analysis, Omega Healthcare Investors (BSP:O2HI34) is currently considered Modestly Overvalued. The stock's GF Value™ is R$60.64, compared to a current price of R$77.02 — trading 27% above its estimated fair value. The current Debt-to-Equity is 0.86, which is 34% below median its 10-year median of 1.30 and 8.9% above the REITs industry median of 0.79. Omega Healthcare Investors' overall GF Score™ is 49/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For Omega Healthcare Investors (BSP:O2HI34), the current Debt-to-Equity is 0.86 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Omega Healthcare Investors (BSP:O2HI34) Overvalued in 2026?

Based on GuruFocus' analysis, Omega Healthcare Investors stock appears to be overvalued. The current stock price of R$77.02 is trading 27% above its estimated GF Value™ of R$60.64. GuruFocus considers Omega Healthcare Investors to be Modestly Overvalued.

Key valuation signals for BSP:O2HI34:

  • Debt-to-Equity: 0.86 (34% below median its 10-year median of 1.30)
  • GF Value™: R$60.64 vs. price of R$77.02 (27% above fair value)
  • GF Score™: 49/100 with 6 warning signs
  • Industry Position: 8.9% above the REITs median (#400 of 696)

No single metric tells the full story. See the BSP:O2HI34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Omega Healthcare Investors Business Description

Industry Real EstateREITs
Address 303 International Circle, Suite 200, Hunt Valley, MD, USA, 21030
Omega Healthcare Investors Inc is a real estate investment trust that invests in healthcare-related real estate properties located in the United States (U.S.), the United Kingdom (U.K.), and Canada. The company's objective is to provide attractive returns to investors while serving as the preferred capital partner to its third-party healthcare operating companies and affiliates, as well as other third-party healthcare operators, allowing them to focus on delivering a high level of care to their resident patients. Omega's investment portfolio mainly consists of skilled nursing facilities, assisted living facilities (ALFs), including care homes in the U.K., independent living facilities, rehabilitation and acute care facilities, and continuing care retirement communities.
49GF Score

Get the complete analysis for BSP:O2HI34

Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$77.02
Price
R$60.64
GF Value